期刊文献+

LncRNA PVT1 miR-30d表达与上皮性卵巢癌患者化疗敏感性及预后的关系 被引量:5

Relationships between expressions of LncRNA PVT1 and MiR-30d with chemosensitivity and prognosis of epithelial ovarian cancer patients
下载PDF
导出
摘要 目的探讨LncRNA PVT1、miR-30d表达与上皮性卵巢癌患者化疗敏感性及预后的关系。方法选取2012年2月~2014年1月行手术治疗的76例上皮性卵巢癌患者的癌组织标本作为上皮性卵巢癌组,另选取本院收治的76例良性卵巢肿瘤作为对照组。检测LncRNA PVT1、miR-30d相对表达量,根据表达水平分为高表达组与低表达组;根据对顺铂(DDP)、阿霉素(ADM)、环磷酰胺(CTX)的敏感性将患者分为敏感组和耐药组并对比LncRNA PVT1、miR-30d表达情况;应用Pearson法对miR-30d和LncRNA PVT1表达的相关性进行分析;采用Kaplan-Meier对上皮性卵巢癌患者5年的生存情况进行分析。结果与对照组相比,上皮性卵巢癌组miR-30d表达水平降低(P<0.05),LncRNA PVT1表达水平升高(P<0.05)。miR-30d、LncRNA PVT1表达均与FIGO分期、分化程度密切相关(P<0.05)。DDP、ADM敏感组miR-30d表达水平显著高于耐药组(P<0.05),LncRNA PVT1表达水平显著低于耐药组(P<0.05)。Pearson相关性分析显示上皮性卵巢癌组织中miR-30d和LncRNA PVT1表达呈负相关(P<0.05)。Kaplan-Meier法分析显示miR-30d高表达组5年内总生存率及中位生存时间远高于低表达组(73.7%VS 33.3%,28.0月VS 20.0月,P<0.05);LncRNA PVT1低表达组5年内总生存率及中位生存时间远高于高表达组(81.5%VS 22.4%,27.0月VS 18.0月,P<0.05)。结论上皮性卵巢癌患者癌组织miR-30d低表达,LncRNA PVT1高表达,miR-30d、LncRNA PVT1表达与上皮性卵巢癌患者化疗敏感性及预后有关。 Objective To study the abnormal expressions of long non-coding RNA PVT1(LncRNA PVT1)and micro RNA-30d(miR-30d)in epithelial ovarian cancer,and explore the relationships between LncRNA PVT1 and miR-30d with chemosensitivity and prognosis of patients with epithelial ovarian cancer.Methods 76 patients with epithelial ovarian cancer underwent surgical treatment from February 2012 to January 2014 were selected as the epithelial ovarian cancer group,and 76 patients with benign ovarian tumors in our hospital were selected as the control group.The relative expressions of LncRNA PVT1 and miR-30d were detected by qRT-PCR.According to the sensitivity to Cisplatin(DDP),Adriamycin(ADM),Cyclophosphamide(CTX),the patients were divided into sensitive group and resistant group,and the expressions of LncRNA PVT1 and miR-30d were compared.Pearson method was used to analyze the correlation between the expressions of MV-30d and LncRNA PVT1.Kaplan-Meier was used to analyze the 5-year survival of patients with epithelial ovarian cancer.Results Compared with the adjacent tissue group,the expression of miR-30d in epithelial ovarian cancer group decreased(P<0.05),while the expression of LncRNA-PVT1 increased(P<0.05).The expressions of miR-30d and LncRNA-PVT1 were closely related to FIGO stage and differentiation degree.The expression level of miR-30d in DDP and ADM sensitive group was significantly higher than that in drug resistant group,and the expression level of LncRNA-PVT1 was significantly lower than that in drug resistant group(P<0.05).Pearson correlation analysis showed that the expressions of MV-30d and LncRNA PVT1 were negatively correlated in epithelial ovarian cancer(P<0.05).Kaplan-Meier analysis showed that the 5-year overall survival rate and median survival time of the miR-30d high-expressed group were significantly higher than those of the low-expressed group(73.7%VS 33.3%,28.10months VS 20.10months,P<0.05).The 5-year overall survival rate and median survival time of LncRNA PVT1 low-expressed group were much higher than th
作者 王雯智 郑蕾 李虹 WANG Wenzhi;ZHENG Lei;LI Hong(Department of Gynecology, Shanxi People's Hospital, Xi'an 710068, China;Pharmaceutical College of Xi'an Medical College, Xi'an 710000, China;Department of Obstetrics, Shanxi People's Hospital, Xi'an, 710068, China)
出处 《西部医学》 2020年第5期687-691,共5页 Medical Journal of West China
基金 陕西省社会发展科技攻关项目(2016SF-192)。
关键词 上皮性卵巢癌 长链非编码RNA PVT1 微小RNA-30d 化疗敏感性 异常表达 Epithelial ovarian cancer Long non-coding RNA PVT1 Micro RNA-30d Chemosensitivity Unusual expression
  • 相关文献

参考文献7

二级参考文献42

共引文献119

同被引文献31

引证文献5

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部